Questions the vet will ask: The vet will usually remove some cells from the lump with a fine needle in order to examine them ...

Mast cell activation syndrome, a disorder involving immune cells gone awry, is increasingly recognized as the culprit behind many medical mysteries. The first key to understanding this complex ...

Telomir-1 demonstrated the opposite effect-actively suppressing tumor development, while selectively benefiting healthy cells. In the group treated with Paclitaxel alone, severe toxicity was observed, ...

If you just found out that you or your child has a germ cell tumor, you may have a lot of questions about what it means and what comes next. There are many kinds of germ cell tumors, and only some ...

The global mast cell tumor treatment ... driven by factors like rising cancer prevalence, increasing awareness of treatment options, and development of new therapies. The US market is expected to see ...

GT Wings A pioneering rigid shipping mast has set off on its first journey ... and those from the Formula 1 racing world. "The aerodynamics and all the science behind the America's Cup really ...

Aura Biosciences, Inc. announced positive data from a completed Phase 1 window of opportunity trial ... PSMA-PET imaging1 agent for prostate cancer. HUTCHMED (China) Limited announces that the ...

Have you been paying attention to current events recently? See how many of these 10 questions you can get right. Compiled by Jeremy Engle In an illustrated story, a guest author describes how ...

Type 1 diabetes occurs when the immune system attacks pancreatic beta cells. Type 2 diabetes happens when the body cannot use insulin effectively. The two types differ in symptoms, causes ...

Pet owner Matt Ezyk of Myrtle Beach, South Carolina, experienced this when he noticed his senior dog Jack was lethargic and not eating or drinking much. “The diagnosis was devastating—late ...

The Iditarod is typically called a 1,000-mile (1,609-kilometer) race as mushers and their dogs battle the most challenging elements an Alaska winter can throw at them. However, that mileage has ...

The FDA has cleared the IND application for MRANK-106, allowing for the initiation of phase 1 clinical trials in 2025 to target advanced or metastatic solid tumors, including pancreatic cancer, small ...